CVS Health Corp (BSP:CVSH34)
R$ 31.75 -0.09 (-0.28%) Market Cap: 403.33 Bil Enterprise Value: 794.75 Bil PE Ratio: 9.69 PB Ratio: 0.92 GF Score: 76/100

CVS Health Corp at JPMorgan Healthcare Conference Transcript

Jan 10, 2023 / 04:15PM GMT
Release Date Price: R$47.02 (-2.29%)
Lisa Christine Gill
JPMorgan Chase & Co, Research Division - MD, Head of U.S. Healthcare Technology & Distribution Equity Research and Senior Research Analyst

Good morning. My name is Lisa Gill, and I'm the health care services analyst with JPMorgan. It is so much fun to be back in the big room again this year. It's been 3 years since we've been live. So I am incredibly happy to have with me this morning CVS Health. With us today is CEO, Karen Lynch. Karen will kick off with a few slides and then join myself and CFO, Shawn Guertin, for a fireside chat after her presentation. So with that, Karen?

Karen Sue Lynch
CVS Health Corporation - President, CEO & Director

Thank you, Lisa. Good morning, everyone. It's a pleasure to be with all of you today, and a happy new year to all of you. I'm going to provide an overview of CVS Health, a little more detail than probably normal for those of you who may not be as familiar with CVS Health. And then for those of you who are familiar with CVS Health, it will be somewhat of a refresher.

Before we get

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot